Premium
Treatment of benign cephalic histiocytosis with topical 1% rapamycin ointment
Author(s) -
Habeshian Kaiane,
Silverman Robert A.,
DeKlotz Cynthia M. C.
Publication year - 2019
Publication title -
pediatric dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.542
H-Index - 73
eISSN - 1525-1470
pISSN - 0736-8046
DOI - 10.1111/pde.13800
Subject(s) - medicine , dermatology , upper trunk , trunk , surgery , histiocytosis , pathology , ecology , brachial plexus , disease , biology
We report a pediatric case of extensive, progressive benign cephalic histiocytosis (BCH) involving the face, trunk, and extremities with response of facial lesions to treatment with topical 1% rapamycin. A split‐face model was used to demonstrate improvement on the treated side versus the untreated side. After physician and parental perception of effectiveness, based in part on photodocumentation, subsequently both cheeks were treated with continued improvement.